EQL Pharma AB engages in the manufacture, development and distribution of generic and specialty pharmaceutical products. It offers medicines to pharmacies and hospitals in the Nordic region. The company was founded by Karin Wehlin and Lars Christer Fedrik Fåhræus in 2006 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company